MAJOR BLEEDING EPISODES AMONG PATIENTS WITH HCC DURING SORAFENIB TREATMENT: THE DARK SIDE OF A RELATIVELY SAFE DRUG? / DE SANTIS, A., Iegri, C., Trapani, S., Lupo, M., F., G., Bassanelli, C., Attili, F., G., G., Attili, A.F.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - STAMPA. - 44 Suppl 2:(2012), pp. S136-S137. (18th National Congress of Digestive Diseases, Italian Federation of Societies of Digestive Diseases – FISMAD Naples 28–31 March 2012) [10.1016/s1590-8658(12)60378-8].
MAJOR BLEEDING EPISODES AMONG PATIENTS WITH HCC DURING SORAFENIB TREATMENT: THE DARK SIDE OF A RELATIVELY SAFE DRUG?
DE SANTIS, Adriano;IEGRI, CLAUDIA;TRAPANI, Silvia;LUPO, MARINELLA;BASSANELLI, CHIARA;ATTILI, FABIA;ATTILI, Adolfo Francesco
2012
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


